Sports medicine expert to present ‘Models of Injury Prevention’ at AMSSM conference

NewsGuard 100/100 Score

Roald Bahr, MD, PhD, will be presenting "Models of Injury Prevention" at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, GA on Saturday, April 21, 2012.

Dr. Bahr is professor of sports medicine and chair of the Oslo Sports Trauma Research Center at the Norwegian School of Sports Sciences. He is also the Chief Medical Officer of the Norwegian Olympic Committee and its National Training Center. Dr. Bahr is the president of the Medical Commission of the International Volleyball Federation (FIVB), and a member of the IOC Medical Commission - Medical and Scientific Group. His main research area is sports injury prevention.

Sports injuries can happen because of poor conditioning, trauma, or muscle overuse. The AMSSM meeting is devoting special sessions to discuss new and innovative models for injury prevention. This will be including but not limited to understanding the multifactorial model for injury causation and discussing the adaptations and maladaptations in the shoulder in the throwing athlete.

The conference features lectures and research addressing the most challenging topics in sports medicine today including prevention of sudden death, cardiovascular issues in athletes, concussion, biologic therapies, and other controversies facing the field of sports medicine.

More than 1,200 sports medicine physicians from across the United States and 12 countries around the world are attended the meeting.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections